Stock listing

A2PLR5 Stock Price, News, Filings & Events — Adaptive Biotechnologies Corporation

Selected listing: A2PLR5 · LSX · EUR · DE

A2PLR5:LSX represents Adaptive Biotechnologies Corporation, a company focused on leveraging its proprietary technology platform to decode the adaptive immune system for disease detection and treatment. Recent developments include advancements in their immune profiling capabilities and partnerships aimed at enhancing their diagnostic offerings. The company regularly updates its filings and news releases to keep investors informed about its progress and market strategies. Adaptive Biotechnologies continues to navigate the evolving landscape of biotechnology, positioning itself for future growth and innovation.

A2PLR5:LSXEURDEUpdated July 24, 2026
Adaptive Biotechnologies Corporation logo
Ticker
A2PLR5:LSX
Asset type
Stock
Market cap
$3.56B
Sector
Health Technology
Industry
Biotechnology
Exchange
LSX
Currency
EUR

Adaptive Biotechnologies Corporation A2PLR5:LSX stock context

A2PLR5:LSX represents Adaptive Biotechnologies Corporation, a company focused on leveraging its proprietary technology platform to decode the adaptive immune system for disease detection and treatment. Recent developments include advancements in their immune profiling capabilities and partnerships aimed at enhancing their diagnostic offerings. The company regularly updates its filings and news releases to keep investors informed about its progress and market strategies. Adaptive Biotechnologies continues to navigate the evolving landscape of biotechnology, positioning itself for future growth and innovation.

Research Adaptive Biotechnologies Corporation

Alternate listings